Cannabis should be removed from Schedule 1 of the U.S. Controlled Substances Act so that it can be better researched, according to a statement by the American Heart Association (AHA).
Regulators should also start standardizing concentrations of THC and CBD content in recreational and medicinal marijuana, according to the AHA writing group led by Robert Page II, PharmD, MSPH, of University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Denver.